Issue 4/2023
Content (8 Articles)
Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem
Rohita Sharma, Sumaira Ahmed, Judy Campagnari, Wendi Huff, Lelainia Lloyd
Tackling Counterfeit Drugs: The Challenges and Possibilities
Ranjana Pathak, Vaibhav Gaur, Himanshu Sankrityayan, Jaideep Gogtay
Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant
Andrea Phillips-Beyer, Ariane K. Kawata, Leah Kleinman, Dalma Seboek Kinter
Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries
Kampadilemba Ouoba, Hélène Lehmann, Arsène Zongo, Jean-Yves Pabst, Rasmané Semdé
Interpersonal Values of Patients Participating in Phase II–III Clinical Trials: Implications for Clinical Trial Representativeness
Rita Gouveia, Vitor Tedim Cruz, Joana Antão, Luís Almeida
75th Annual Meeting of the American Academy of Neurology (AAN 2023)
Sue Pochon